“…Similar to IFN-I treatment of IBD patients with mixed results, in which a few of clinical studies initially reported promising results but most of these studies failed to demonstrate beneficial therapeutic effect or showed even exacerbations, 41 previous reports showed some controversies for the role of IFN-I signaling in the development of DSS-induced colitis when Ifnar1 À / À mice were used for the comparison of WT mice. 26,42,43 The reason why the IFN-I signaling has inconsistency for the control of DSS-induced acute colitis remains unclear, but the discrepancies might be explained by amount of oral application of DSS, 43 experimental conditions, and environmental factors. Taken together, these results suggest that pDCs regulate the colonic inflammation independent of their pathophysiological production of IFN-I.…”